Triage of Limited Versus Extensive Disease on 18F-FDG PET/CT Scan in Small Cell lung Cancer
Objective(s): Small cell lung cancer (SCLC) is an aggressive neuroendocrine carcinoma, which accounts for 10-15% of pulmonary cancers and exhibits early metastatic spread. This study aimed to determine the added value of 18F-FDG PET/CT imaging in tumor, node, and metastasis (TNM) staging of SCLC, co...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2017-06-01
|
Series: | Asia Oceania Journal of Nuclear Medicine and Biology |
Subjects: | |
Online Access: | http://aojnmb.mums.ac.ir/article_8751_aff6ca7a9234a2cbe5583ee76a7ed538.pdf |
_version_ | 1818442375013335040 |
---|---|
author | Saima Riaz Humayun Bashir Imran Niazi |
author_facet | Saima Riaz Humayun Bashir Imran Niazi |
author_sort | Saima Riaz |
collection | DOAJ |
description | Objective(s): Small cell lung cancer (SCLC) is an aggressive neuroendocrine carcinoma, which accounts for 10-15% of pulmonary cancers and exhibits early metastatic spread. This study aimed to determine the added value of 18F-FDG PET/CT imaging in tumor, node, and metastasis (TNM) staging of SCLC, compared to the conventional computed tomography (CT) scan and its potential role as a prognosticator.Methods: This retrospective review was conducted on 23 patients, who were histopathologically diagnosed to have SCLC and referred for undergoing 18F-FDG PET/CT scanning during October 2009-December 2015. The rate of agreement between the CT and 18F-FDG PET/CT findings for TNM staging was calculated using the Cohen’s kappa (κ). The median follow-up time was eight months, ranging 27-3 months). The overall and disease-free survival rates were calculated based on the extent of disease.Results: 19 cases were male and four female with the mean age of 58±9 years. The 18F-FDG PET/CT identified limited and extensive diseases in 2 (8.7%) and 21 (91.3%) patients, respectively. In addition, the results of the Cohen’s kappa demonstrated a strong (κ=0.82), fair (κ=0.24), and poor (κ=0.12) agreement between the PET/CT and CT findings for determining tumor, node, and metastasis stages, respectively. The 18F-FDG PET/CT scans upstaged disease in 47% of the cases with visceral and osseous metastasis. The disease-free survival rates for the limited and extensive diseases were 100% and 23% within the 12-month follow-up. In addition, 8 (35%) patients expired during the follow-up period.Conclusion: Improved nodal and metastatic disease identification highlights the role of 18F-FDG PET/CT scanning in initial staging of SCLC with prognostic implications. |
first_indexed | 2024-12-14T18:43:08Z |
format | Article |
id | doaj.art-1e3782aafe144b9e9ede2d876e80eecf |
institution | Directory Open Access Journal |
issn | 2322-5718 2322-5726 |
language | English |
last_indexed | 2024-12-14T18:43:08Z |
publishDate | 2017-06-01 |
publisher | Mashhad University of Medical Sciences |
record_format | Article |
series | Asia Oceania Journal of Nuclear Medicine and Biology |
spelling | doaj.art-1e3782aafe144b9e9ede2d876e80eecf2022-12-21T22:51:27ZengMashhad University of Medical SciencesAsia Oceania Journal of Nuclear Medicine and Biology2322-57182322-57262017-06-015211311810.22038/aojnmb.2017.87518751Triage of Limited Versus Extensive Disease on 18F-FDG PET/CT Scan in Small Cell lung CancerSaima Riaz0Humayun Bashir1Imran Niazi2Department of Nuclear medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, PakistanDepartment of Nuclear medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, PakistanDepartment of Radiology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, PakistanObjective(s): Small cell lung cancer (SCLC) is an aggressive neuroendocrine carcinoma, which accounts for 10-15% of pulmonary cancers and exhibits early metastatic spread. This study aimed to determine the added value of 18F-FDG PET/CT imaging in tumor, node, and metastasis (TNM) staging of SCLC, compared to the conventional computed tomography (CT) scan and its potential role as a prognosticator.Methods: This retrospective review was conducted on 23 patients, who were histopathologically diagnosed to have SCLC and referred for undergoing 18F-FDG PET/CT scanning during October 2009-December 2015. The rate of agreement between the CT and 18F-FDG PET/CT findings for TNM staging was calculated using the Cohen’s kappa (κ). The median follow-up time was eight months, ranging 27-3 months). The overall and disease-free survival rates were calculated based on the extent of disease.Results: 19 cases were male and four female with the mean age of 58±9 years. The 18F-FDG PET/CT identified limited and extensive diseases in 2 (8.7%) and 21 (91.3%) patients, respectively. In addition, the results of the Cohen’s kappa demonstrated a strong (κ=0.82), fair (κ=0.24), and poor (κ=0.12) agreement between the PET/CT and CT findings for determining tumor, node, and metastasis stages, respectively. The 18F-FDG PET/CT scans upstaged disease in 47% of the cases with visceral and osseous metastasis. The disease-free survival rates for the limited and extensive diseases were 100% and 23% within the 12-month follow-up. In addition, 8 (35%) patients expired during the follow-up period.Conclusion: Improved nodal and metastatic disease identification highlights the role of 18F-FDG PET/CT scanning in initial staging of SCLC with prognostic implications.http://aojnmb.mums.ac.ir/article_8751_aff6ca7a9234a2cbe5583ee76a7ed538.pdf18F FDG PET-CT scansmall cell lung cancerDisease free survival |
spellingShingle | Saima Riaz Humayun Bashir Imran Niazi Triage of Limited Versus Extensive Disease on 18F-FDG PET/CT Scan in Small Cell lung Cancer Asia Oceania Journal of Nuclear Medicine and Biology 18F FDG PET-CT scan small cell lung cancer Disease free survival |
title | Triage of Limited Versus Extensive Disease on 18F-FDG PET/CT Scan in Small Cell lung Cancer |
title_full | Triage of Limited Versus Extensive Disease on 18F-FDG PET/CT Scan in Small Cell lung Cancer |
title_fullStr | Triage of Limited Versus Extensive Disease on 18F-FDG PET/CT Scan in Small Cell lung Cancer |
title_full_unstemmed | Triage of Limited Versus Extensive Disease on 18F-FDG PET/CT Scan in Small Cell lung Cancer |
title_short | Triage of Limited Versus Extensive Disease on 18F-FDG PET/CT Scan in Small Cell lung Cancer |
title_sort | triage of limited versus extensive disease on 18f fdg pet ct scan in small cell lung cancer |
topic | 18F FDG PET-CT scan small cell lung cancer Disease free survival |
url | http://aojnmb.mums.ac.ir/article_8751_aff6ca7a9234a2cbe5583ee76a7ed538.pdf |
work_keys_str_mv | AT saimariaz triageoflimitedversusextensivediseaseon18ffdgpetctscaninsmallcelllungcancer AT humayunbashir triageoflimitedversusextensivediseaseon18ffdgpetctscaninsmallcelllungcancer AT imranniazi triageoflimitedversusextensivediseaseon18ffdgpetctscaninsmallcelllungcancer |